>https://www.cureus.com/articles/68051-toxic-epidermal-necrolysis-post-covid-19-vaccination%E2%80%94first-reported-case
The patient received two doses of tumor necrosis factor-alpha inhibitor (etanercept) and she stopped developing new lesions after two days of the initial dose; complete healing was observed after 22 days and no side effects were observed in our patient. This case demonstrates an extremely rare complication to the COVID-19 vaccine. The benefits of receiving the COVID-19 outweigh the potential risk.